NCT02525601

Brief Summary

The objective is to investigate the Clinical, Radiographic, Roentgen Stereophotogrammetric behaviour and patient outcome when using the Triathlon total knee prosthesis in a prospective randomized clinical trial.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
7mo left

Started Mar 2009

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress97%
Mar 2009Dec 2026

Study Start

First participant enrolled

March 1, 2009

Completed
6.3 years until next milestone

First Submitted

Initial submission to the registry

June 11, 2015

Completed
2 months until next milestone

First Posted

Study publicly available on registry

August 17, 2015

Completed
11.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2026

Last Updated

May 7, 2026

Status Verified

September 1, 2025

Enrollment Period

17.8 years

First QC Date

June 11, 2015

Last Update Submit

May 6, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Assessment of fixation and stability of the Triathlon total knee prosthesis by Roentgen Stereophotogrammetric Analysis (RSA)

    Assessment of fixation and stability of the Triathlon total knee prosthesis by Roentgen Stereophotogrammetric as a predictor of late mechanical loosening.

    10 years follow-up; UPDATE: time frame extended up to 15 years outcomes

Secondary Outcomes (4)

  • Investigation of patient outcome with radiographic analysis

    3 months, 1, 2, 5, 7 and 10 years; UPDATE: extended 12 and 15 years

  • Investigation of clinical performance and patient outcome with Knee Society Score (KSS)

    pre-operative, 3 months, 1, 2, 5, 7 and 10 years; UPDATE: extended 12 and 15 years

  • Investigation of clinical performance and patient outcome with Knee Injury and Osteoarthritis Outcome Score (KOOS) patient questionnaire

    pre-operative, 3 months, 1, 2, 5, 7 and 10 years; UPDATE: extended 12 and 15 years

  • Investigation of clinical performance and patient outcome with EuroQuol-5 dimension (EQ-5D) patient questionnaire

    pre-operative, 3 months, 1, 2, 5, 7 and 10 years; UPDATE: extended 12 and 15 years

Study Arms (2)

Triathlon CR cemented

ACTIVE COMPARATOR

Triathlon Cruciate Retaining knee with cemented fixation randomised versus Triathlon Cruciated Retaining knee with uncemented fixation. The aim with this study is to evaluate the uncemented Peri-Apatite (PA) knee fixation and migration properties versus the cemented version.

Device: Triathlon CR cemented

Triathlon CR uncemented

ACTIVE COMPARATOR

Triathlon Cruciate Retaining knee with cemented fixation randomised versus Triathlon Cruciated Retaining knee with uncemented fixation. The aim with this study is to evaluate the uncemented PA knee fixation and migration properties versus the cemented version.

Device: Triathlon CR uncemented

Interventions

Implantation of Knee Prosthesis

Triathlon CR cemented

Implantation of Knee Prosthesis

Triathlon CR uncemented

Eligibility Criteria

Age18 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients suffering exclusively from osteo arthritis, Stage II-V \[Ahlbäck Trauma Score, 1968 391\] will be operated.
  • Patients requiring knee prosthesis, suitable for the use of Duracon and Triathlon knee system
  • Patients who understand the conditions of the study and are willing and able to comply with the post-operative scheduled clinical and radiographical evaluations and the prescribed rehabilitation.
  • Patients who signed the Ethics Committee approved Informed Consent Form prior to surgery.

You may not qualify if:

  • Previous major knee surgery
  • Other significant disabling problems from the muscular-skeletal system than in the knees
  • Obese patients where obesity is severe enough to affect subject's ability to perform activities of daily living (body mass index, kg/m2: BMI above 35).
  • Patients with active or suspected infection.
  • Patients with malignancy - active malignancy.
  • Patients with severe osteoporosis, Paget's disease, renal osteodystrophy.
  • Patients immunologically suppressed, or receiving steroids in excess of physiologic dose requirements.
  • The patient has a neuromuscular or neurosensory deficit which would limit the ability to assess the performance of the device or the patient has a neurological deficit which interferes with the patient's ability to limit weight bearing or places an extreme load on the implant during the healing period.
  • Female patients planning a pregnancy during the course of the study.
  • Patients with systemic or metabolic disorders leading to progressive bone deterioration.
  • Patients, who as judged by the surgeon, are mentally incompetent or are unlikely to be compliant with the prescribed post-operative routine and follow-up evaluation schedule.
  • Patients with other severe concurrent joint involvements, which can affect their outcome.
  • Patients with other concurrent illnesses, which are likely to affect their outcome such as sickle cell anaemia, systemic lupus erythematosus or renal disease requiring dialysis.
  • Patients under the protection of law (e.g. guardianship).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Skånevård Kryh Division Kirurgi och Ortopedkliniken Hässleholm

Hässleholm, Skåne County, 281 38, Sweden

Location

Study Officials

  • Sören Toksvig-Larsen, MD

    Skånevård Kryh Division Kirurgi och Ortopedkliniken Hässleholm

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 11, 2015

First Posted

August 17, 2015

Study Start

March 1, 2009

Primary Completion (Estimated)

December 1, 2026

Study Completion (Estimated)

December 1, 2026

Last Updated

May 7, 2026

Record last verified: 2025-09

Locations